Amendment to pre-order trial for Fluoroquinolone Products

Introduction

The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral neuropathy lawsuits involving Avelox, Cipro, and Levaquin are a part of the multidistrict litigation 2642 in the U.S. District Court, District of Minnesota. January 19, 2018, is the deadline for completion of case-specific discovery for Avelox-only and Cipro-only cases. As of today, the bellwether trials begin from November 2018 for the Avelox-only cases and from March 4, 2019, for the Cipro-only cases

Comments

New Front Emerges in Fight Against Synthetic Opioids

Categories: Opioids

The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…

Exactech to Pay $8M to Settle Defective Knee Implant Suit

Categories: Attune Knee System

Medical device maker Exactech has agreed to an $8 million settlement to resolve allegations that it hid defects in a widely used line of artificial knee implants.

The implants have been linked to thousands of patient injuries and sparked…

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Amendment to pre-order trial for Fluoroquinolone Products